ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Market Movers(Regular)

View all
NasdaqNYSEAMEXOTCTSXEuronextLSE

NASDAQ Market Status

Advancing
2,494(63.41%)
Declining
1,401(35.62%)
Unchanged
38(0.97%)
  • % Gainers
  • % Losers
  • Most Active
TickerNamePriceChangeChange %Volume
AVTX LogoAVTXAvalo Therapeutics Inc25.63520.89439.68%15,741,944
XLO LogoXLOXilio Therapeutics Inc1.691.05164.48%22,359,748
BDRX LogoBDRXBiodexa Pharmaceuticals PLC1.590.73185.10%59,437,875
APAC LogoAPACStoneBridge Acquisition Corporation9.602.7339.74%29,873
PIK LogoPIKKidpik Corporation4.561.2939.45%8,062,971
CERO LogoCEROCERo Therapeutics Holdings Inc2.25990.629938.64%688,074
OTRK LogoOTRKOntrak Inc0.82080.225837.95%20,093,318
PEGR LogoPEGRProject Energy Reimagined Acquisition Corporation11.873.2137.07%19,331
PEGRU LogoPEGRUProject Energy Reimagined Acquisition Corporation14.333.7134.93%6,006
HUBCW LogoHUBCWHub Cyber Security Ltd0.01790.004129.71%600
NXL LogoNXLNexalin Technologies Inc1.000.2228.21%542,513
PMEC LogoPMECPrimech Holdings Ltd1.92-1.96-50.52%2,015,516
NBSTW LogoNBSTWNewbury Street Acquisition Corporation0.042279-0.02622-38.28%1,750
GMDA LogoGMDAGamida Cell Ltd0.0426-0.0166-28.04%35,228,415
DTST LogoDTSTData Storage Corporation5.72-1.92-25.13%438,527
UGRO LogoUGROUrban Gro Inc1.3801-0.4349-23.96%290,462
TNXP LogoTNXPTonix Pharmaceuticals Holding Corporation0.26-0.0669-20.46%6,978,540
KOD LogoKODKodiak Sciences Inc6.0499-1.40-18.79%805,164
MLKN LogoMLKNMillerKnoll Inc25.54-4.99-16.34%1,345,828
NCNA LogoNCNANuCana PLC0.2607-0.04595-14.98%792,967
SEZL LogoSEZLSezzle Inc78.6701-13.83-14.95%58,342
ABTS LogoABTSAbits Group Ltd0.68-0.117-14.68%397,910
NKLA LogoNKLANikola Corporation1.0250.115912.75%90,765,663
BDRX LogoBDRXBiodexa Pharmaceuticals PLC1.590.73185.10%59,437,875
AKAN LogoAKANAkanda Corporation0.19850.033620.38%52,849,985
CISS LogoCISSC3is Inc0.0335-0.0047-12.30%37,200,748
GMDA LogoGMDAGamida Cell Ltd0.0426-0.0166-28.04%35,228,415
MARA LogoMARAMarathon Digital Holdings Inc24.552.4811.24%33,262,680
AKBA LogoAKBAAkebia Therapeutics Inc2.13-0.11-4.91%31,523,907
TSLA LogoTSLATesla Inc177.7134-2.12-1.18%30,091,642
SQQQ LogoSQQQProShares UltraPro Short QQQ10.4090.0090.09%26,656,372
KTRA LogoKTRAKintara Therapeutics Inc0.1040.014516.20%25,679,520
AMD LogoAMDAdvanced Micro Devices Inc182.102.511.40%23,253,268
TradesView all

Big Movers

11:00
Business Wire

Gilead Sciences, Inc. (Nasdaq: GILD) and Xilio Therapeutics, Inc. (Nasdaq: XLO) today announced an exclusive license agreement to develop and commercialize Xilio’s Phase 1 tumor-activated IL-12 program, XTX301.

12:30
PR Newswire (US)

SINGAPORE, March 28, 2024 /PRNewswire/ -- Primech Holdings Limited (Nasdaq: PMEC) ("Primech" or the "Company"), an established technology-driven facilities services provider in the public and private sectors operating mainly in Singapore, provides a financial and corporate update coincident with the filing of the Company's financial results for the six months ended September 30, 2023. These financial results are for periods prior to the Company's initial public offering ("IPO") in October of 2023.

12:02
Business Wire

Kidpik Corp. (NASDAQ: PIK) ("kidpik” or the "Company"), an online clothing subscription-based e-commerce company, today announced that the Company received written notification from the Listing Qualification Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that is has regained full compliance with the Minimum Bid Price Requirement.

10:30
PR Newswire (US)

Three clinical programs present diversified opportunities in and outside the existing anti-VEGF market and are being progressed toward Phase 3 value inflection points  New Phase 3 GLOW2 study of tarcocimab in diabetic retinopathy actively recruiting  Phase 1b study of KSI-101 planned for 2Q2024 with the goal of initiating dual pivotal studies in 2024  New Phase 3 DAYBREAK study in wet AMD to include KSI-501 and tarcocimab investigational groups versus aflibercept targeted to start recruitment mid-2024 following completion of FDA discussions  Investor day to be scheduled after on-going regulatory interactions completedPALO ALTO, Calif., March 28, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and ...

Ticker Buzz Cloud
What is the Buzz Cloud?
  • The Buzz Cloud keeps track of how often tickers are mentioned to indicate the "level of buzz".
  • The larger the text, the more often the ticker is mentioned by the community.
  • You can use this page to spot trading opportunities based on the increase or decrease in the level of buzz.

Unlock more advanced trading tools

Join ADVFN today

Top Cryptocurrencies

View All Cryptos
Crypto Market Status
Advancing
8955(33%)
Declining
2877(10%)
Unchanged
14516(57%)
Ticker Name Price Change Change % Market Cap Volume
BTCBitcoin71,195.721,731.152.49%1.4T7,581,295,332
ETHEthereum3,582.9682.902.37%431.03B3,898,383,195
USDTTether USD1.000.000560.06%97.84B1,033,665,059
BNBBinance Coin584.3910.261.79%92.44B514,650,269
SOLSolana186.540.4200.23%82.48B1,683,514,224
STETHstETH3,572.56108.133.12%35.07B13,012,474
XRPRipple0.62220.01071.75%33.91B562,150,306
DOGEDogecoin0.214980.0249413.12%30.81B2,845,453,404
USDCUSD Coin0.9999-0.0001-0.01%28.07B1,433,361,766
ADACardano0.65190.00430.66%22.97B191,258,307

Economic Calendar

This week's major US economic reports, Fed Speakers, indicators and market-moving events.
View full calendar